Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Study provides new insight into how cells maintain their identity

Study provides new insight into how cells maintain their identity

Study uncovers new factor in the development of childhood lymphoma

Study uncovers new factor in the development of childhood lymphoma

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

New method developed to address failures in promising anti-cancer drug

New method developed to address failures in promising anti-cancer drug

Scientists use CAR-T cells to reverse cardiac fibrosis

Scientists use CAR-T cells to reverse cardiac fibrosis

CAR T-cell therapy may be viable treatment option for heart disease

CAR T-cell therapy may be viable treatment option for heart disease

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

Scientists reveal the structure of a key protein in Epstein-Barr virus infection

Scientists reveal the structure of a key protein in Epstein-Barr virus infection

Johns Hopkins researchers estimate real-world prevalence of prurigo nodularis

Johns Hopkins researchers estimate real-world prevalence of prurigo nodularis

Removing tumor's protective wall could help boost the effects of cancer treatments

Removing tumor's protective wall could help boost the effects of cancer treatments

New therapy found to be effective for patients with a particular type of bone marrow cancer

New therapy found to be effective for patients with a particular type of bone marrow cancer

Cancer survivors could be at greater risk of cardiovascular diseases

Cancer survivors could be at greater risk of cardiovascular diseases

Researchers analyze precise mechanism of binding reaction in PUVA therapy

Researchers analyze precise mechanism of binding reaction in PUVA therapy

Researchers develop new gene editing system that could be used for anticancer immunotherapy

Researchers develop new gene editing system that could be used for anticancer immunotherapy

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Innovative technology could help treat cancer more selectively and effectively

Innovative technology could help treat cancer more selectively and effectively

People who have a parent, sibling, or child with blood cancer have higher risk of disease

People who have a parent, sibling, or child with blood cancer have higher risk of disease

Innovative technology could treat cancer more selectively and effectively

Innovative technology could treat cancer more selectively and effectively

Beckman Coulter Life Sciences publishes ClearLLab Control Cells white paper

Beckman Coulter Life Sciences publishes ClearLLab Control Cells white paper